Market Cap
₹2,576 Cr.
P/E
30.24
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
13.33%
3yr Average
5.24%
5yr Average
4.79%
Net Profit Margin
Latest
27.29%
3yr Average
10.61%
5yr Average
8.94%
ROCE
Latest
6.57%
3yr Average
4.06%
5yr Average
4.35%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
1.80% (as of Jul 22)
Anti - Diabetes - Market Share
0.06% (as of Jul 22)
Anti-Infectives - Market Share
0.09% (as of Nov 21)
Antineo Plastic - Market Share
0.14% (as of May 19)
Blood Related - Market Share
0.72% (as of Jul 22)
Cardiovascular - Market Share
0.03% (as of Nov 21)
Dermatology - Market Share
0.01% (as of Aug 18)
Endocrinology - Market Share
0% (as of Jul 22)
Gastro-Intestinal - Market Share
0.85% (as of Nov 21)
Gynecology - Market Share
0.51% (as of Nov 21)
Neurological - Market Share
6.46% (as of Nov 21)
Ophthalmology - Market Share
2.40% (as of Nov 21)
Pain - Market Share
0.55% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.17% (as of Nov 21)
Respiratory - Market Share
0.43% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    Peer Comparison
    Brands
    Voveran
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis